Intelligent Diabetes Management System

A novel, integrated system combining Canagliflozin-based pharmaceutical compositions with cutting-edge technologies such as AI, IoT, blockchain, and advanced materials for personalized diabetes management, real-time monitoring, and targeted drug delivery.

The original patent disclosed a pharmaceutical composition comprising Canagliflozin, but it had limitations in terms of patient adherence, dosage optimization, and real-time monitoring. The new inventive concept addresses these limitations by integrating the patented composition with distinct technologies to create a more powerful system.

The system comprises a pharmaceutical composition of Canagliflozin, a wearable IoT device for monitoring glucose levels, and an AI-powered algorithm for predicting optimal dosage and administration schedules. Additionally, the system may include a blockchain-based data management platform for real-time monitoring of Canagliflozin efficacy, a novel, bio-absorbable material for targeted drug delivery, and a mobile application for remote patient monitoring and personalized coaching. The system's components interact to provide personalized guidance on medication adherence and lifestyle modifications.

The new claims introduce novel synergies between the pharmaceutical composition and advanced technologies, enabling real-time monitoring, personalized dosage optimization, and targeted drug delivery. These integrations are non-obvious and provide a significant improvement over the original patent.

Alternative embodiments may include different IoT devices, AI algorithms, or blockchain platforms. Variations may include the use of different pharmaceutical compositions, materials, or dosage forms. The inventive concept can be adapted for other diseases or conditions requiring personalized management and monitoring.

The Intelligent Diabetes Management System has significant commercial potential in the pharmaceutical, healthcare, and technology industries. It can be marketed to pharmaceutical companies, healthcare providers, and patients seeking personalized diabetes management solutions.